Skip to content
    CELC stock page

    Celcuity Inc.

    CELC · earnings call history

    3 calls analysed
    1. Jun 2026Q2 FY26Aug 13, 2026

      Celcuity Q2 FY26 — REVTORPYK Approval, NCCN Recommendation, and PIK3CA Mutant Cohort Data

      Read the brief
    2. Mar 2026Q1 FY26May 14, 2026

      Celcuity Q1 FY26 — Gedatolisib Advances with Positive VIKTORIA-1 Data and Expanded VIKTORIA-2 Study

      Read the brief
    3. Dec 2025Q4 FY25Mar 25, 2026

      Celcuity Q4 FY25 — Gedatolisib NDA Accepted with Priority Review and Strong Clinical Data

      Read the brief

    Browse all US companies on the earnings-call register.